Penczek Ronald W 4

What Happened Ronald W. Penczek, Controller & Chief Accounting Officer of Elevance Health (ELV), exercised stock options to acquire a total of 1,531 shares on May 19, 2026 (654 shares at $271.27 for $177,411 and 877 shares at $311.48 for $273,168 — combined cost $450,579) and then sold those 1,531 shares in the open market at $403.13 per share for total proceeds of $617,192. The filing also shows derivative entries at $0 which reflect the cancellation/disposition of the option interests upon exercise.

Key Details

• Transaction date: May 19, 2026; Form 4 filed May 20, 2026 (filed next business day — not indicated as late).
• Options exercised (transaction code M): 654 @ $271.27 (cost $177,411) and 877 @ $311.48 (cost $273,168).
• Open-market sale (transaction code S): 1,531 shares @ $403.13, proceeds $617,192; executed in multiple trades at the same price.
• Net cash difference (sale proceeds minus exercise cost): $617,192 − $450,579 = $166,613 (before taxes/fees).
• Footnotes: F1 — balance includes 10.21 shares acquired via dividend reinvestment plan on Mar 25, 2026; F2 — sale executed in multiple trades at $403.13; F3 — options were fully vested.
• The filing does not disclose a total post-transaction holding in the summary data provided here.

Context This was an exercise of vested options followed by an immediate sale of the resulting shares (a common cashless or simultaneous sale pattern). Such transactions convert option interests into shares and then monetize them; they are routine for executives exercising vested awards and do not, by themselves, indicate a change in view about the company.